Inferior vena cava filter
An inferior vena cava filter (IVC filter) is a type of vascular filter, a medical device that is implanted by interventional radiologists or vascular surgeons into the inferior vena cava to presumably prevent life-threatening pulmonary emboli (PEs). Their effectiveness and safety profile is not well established, and in general, they are only recommended in some high-risk scenarios. They are not intended to be a replacement for medical management of venous thromboembolism (VTE). However, in cases where patients are at high risk of developing a clinically significant PE and cannot be sufficiently anticoagulated, placement of an IVC Filter may be recommended. To date, there has been only one randomized controlled trial completed on IVC Filters. This study found that IVC Filters reduced the incidence of PE but increased the incidence of deep vein thrombosis (DVT). All patients were on anticoagulation during the study. Results from the PREPIC study and other studies which have shown many long-term complications of IVC Filters led to the introduction of retrievable IVC Filters. The first retrievable IVC Filters were approved by FDA in 2003 and 2004.
In 2012, the American College of Chest Physicians recommended IVC filters for those with contraindications to anticoagulation who either have acute PE or acute proximal (above the knee) deep vein thrombosis (DVT).
- 1 Anticoagulation
- 2 Placement
- 3 Indications for use
- 4 Side effects
- 5 IVC filter composition, MRI dangers and effects
- 6 Retrieval
- 7 History
- 8 References
- 9 Cited literature
- 10 External links
In those with initial acute proximal DVT or acute PE who had IVC filters placed instead of anticoagulation, and who have their risk of bleeding resolve, the American College of Chest Physicians suggested, in 2012, that they receive a standard course of anticoagulation. While IVC filters are associated with a long term risk of DVT, they are not, alone, reason enough to maintain extended anticoagulation.
IVC filters are placed endovascularly, meaning that they are inserted via the blood vessels. Historically, IVC filters were placed surgically, but with modern filters that can be compressed into much thinner catheters, access to the venous system can be obtained via the femoral vein (the large vein in the groin), the internal jugular vein (the large vein in the neck) or the arm veins with one design. Choice of route depends mainly on the number and location of any blood clot within the venous system. To place the filter, a catheter is guided into the IVC using fluoroscopic guidance, then the filter is pushed through the catheter and deployed into the desired location, usually just below the junction of the IVC and the lowest renal vein.
Review of prior cross-sectional imaging or a venogram of the IVC is performed before deploying the filter to assess for potential anatomic variations, thrombi within the IVC, or areas of stenoses, as well as to estimate the diameter of the IVC. Rarely, ultrasound-guided placement is preferred in the setting of contrast allergy, renal insufficiency, and when patient immobility is desired. The size of the IVC may affect which filter is deployed, as some (such as the Birds Nest) are approved to accommodate larger cavae. There are situations where the filter is placed above the renal veins (e.g. pregnant patients or women of childbearing age, renal or gonadal vein thromboses, etc.). Also, if there is duplication of the IVC, the filter is placed above the confluence of the two IVCs  or a filter can be placed within each IVC.
Indications for use
While the ability to retrieve a filter does exist for many models, it cannot be guaranteed that all cases of filter placement will allow for, or be indicated for retrieval. Thus, the requirements and indications for permanent placement of filters is used to decide on when to use both permanent and temporary IVC filters.
Long-term risk factors must be considered as well, to include life expectancy of more than six months following insertion, and the ability of the patient to comply with anticoagulation therapy. The decision to use a filter that is temporary vs permanent basically is tied to the expected duration of time that protection is needed to prevent Pulmonary Emboli from passing to the heart and lungs. One such guideline is outlined below:
- Contraindications to anticoagulation; e.g. a patient with DVT or PE who has another condition that puts them at risk of bleeding, such as a recent bleed into the brain, or a patient about to undergo major surgery
- Short Term Risk of PE/Short Term contraindication of anticoagulation: Usually merits a retrievable filter
- Uncertain Risk of PE and/or lack of control for anticoagulation: Usually results in permanent filters for long term management
- Long Term Risk of PE/Recurrent PE/Recurrent DVT: Permanent Filter
While many studies have been done on the efficacy of Vena Cava filters, there still have not been any major studies done on the actual placement and removal of the filters regarding standard guidelines. Which is why the Society of Interventional Radiology created a multidisciplinary panel that developed the following guidelines to see if someone qualifies for implantation:
These are patients that should strongly consider having IVC filter placement, as they are at greatest risk of pulmonary embolus.
- Proven VTE: Venous thromboembolism and contraindication or complication due to anticoagulation therapy
- Recurrent VTE: Despite adequate anticoagulation therapy
This is a maybe category; normally it represents patients who could benefit from an IVC filter, but may be just fine without one as well.
- Proven VTE: High risk of contraindication or complication to arise during anticoagulation thearpy
- Large, free-floating proximal DVT's
- Poor Compliance: INR levels are not stable, not taking medicine as directed
- Thrombolysis: Iliocaval DVT's, which are emboli in the Illiac region
These are usually very controversial reasons to do an IVC filter, and most radiologists and doctors generally will not recommend an IVC filter if other options are available instead.
- No VTE: Anticoagulation therapy is not possible (high risk of bleeding)
- Transient risk of VTE: Trauma, surgical procedures or medical conditions
- Bariatric Patients: Undergoing surgery for weight control, only if BMI greater than 55, previous history of DVT/PE, hypercoagulable state, chronic venous insufficiency, truncal obesity or contraindication to anticoagulation therapy.
Indications for Removing IVC Filter
There is no current published data confirming the benefit of removing an IVC. Because of this, the Society of Interventional Radiology created a multidisciplinary panel that developed the following guidelines to see if someone qualifies for removal:
- No need for Permanent filter: Remove temporary
- Low risk of Significant PE: Continued anticoagulation is working, remove temporary
- No Expected Near-Term high risk PE: Continuation of anticoagulation therapy, remove temporary
- Life expectancy of more than six months: Remove temporary
- Ability to retrieve the filter: No complications, no tear probability, no trauma probability, if so, remove temporary
- Patient/Guardian agrees: Fully consented, fully informed, if so, remove temporary
The main function of a vena cava filter is to prevent death from massive pulmonary emboli. Long-term clinical follow-up studies have shown that this is accomplished in 96% of cases having a standard stainless-steel Greenfield filter.
In August, 2010, the FDA released an Initial Communication on the Risk and Adverse events associated with Long Term use of an inferior vena cava filter. Over a period of about 5 years, they identify 921 events. While not the majority of cases, that number still represents a statistical significance of the use of long-term IVCs.
Of these IVC filter side effects, 328 involved device migration, 146 involved embolizations after detachment of device components, 70 involved perforation of the IVC, and 56 involved filter fracture. Much of the medical community believes that this large number of adverse events is related to the heart filter remaining in place for longer than necessary.
Common issues relating to failure, to include death (the other 4% of cases) include:
- Device-associated morbidity
- Device migration
- Filter embolization
- Filter fracture
- Insertion-site thrombosis
- Perforation of the vena cava
- Recurrent DVT
- Recurrent PE
- Thrombotic complications
- Vena cava thrombosis
Less Common Adverse Reactions
While these side effects are not common (less than 10-20% of patients), many do report issues stemming from the placement and complication of the IVC while inside of the body.
- 9% (12 of 132 patients) delayed filter penetration of the IVC greater than 3 mm
- Parts of filter broke off in 2% (5 of 230 patients)
- Caval filter migrated to heart or pulmonary artery (4 patients)
Numerous small published articles and case studies report describe similar issues to the above. Most notably:
- Filter fracture: Broken struts migrate to retroperitoneum, requiring exploration.
- Perforation into the duodenum: Resulting in severe diarrhea and weight loss.
- Arterial hemorrhage: Requires surgery to avoid death.
- Misplaced Filter: Causes pericardiac tamponade requiring surgery under cardiopulmonary bypass.
- Filter Migration to Right Atrium: Resulting in acute myocardial infarction.
- Filter Lodged in Heart: Causes life-threatening arrhythmia and often requires Pace Makers to resolve condition.
- Heart Migration: Requires surgery to remove IVC from heart.
- Sudden Death: Caused by the filter migrating to an active region in the heart.
- Migration of Filter to Chest: Requires surgery.
- Perforation of filter strut into small-bowel: Requires surgery to repair perforation.
Even though the cases above are the exception, and not the rule, most radiologists object to doing prophylactic filter insertions in patients who do not have thromboembolic diseases. For the most part, whenever possible, interventional radiologists would rather start the patient on anticoagulants than use an IVC, even if requested or referred via a doctor.
IVC filter composition, MRI dangers and effects
While most IVC filters are made of non-ferromagnetic materials, there are a few types that are weakly ferromagnetic. Accordingly, IVC filters fall under the MRI Safe and MRI Conditional categories depending mostly on type of material used during construction. Rarely will one find an MRI Not Safe IVC filter, as most of the steel, and other ferromagnetic material devices have been discontinued via the FDA.
IVC filters are attached to the vena cava via hooks on their ends. Some are compression springs, which compress outward onto the side wall of the vena cava; however, they still have small hooks that retain their location. These hooks aid in the anchoring and healing process, as they allow the tissues to 'ingrow' around them, securing the IVC in place. It is unlikely, then, after 4 to 6 weeks of healing, that an MRI of 1.5 tesla, up to 3 tesla, will cause any level of dislodging to occur for the IVC filter.
As part of the 'routing' survey for MRI studies, patients who have IVC filters will often need verification from the doctor, or medical records, to state that the IVC is safe for the MRI. Most patients with weakly or non-safe ferromagnetic implants will be given a card, which they keep on their person at all time, that can help isolate if it is safe to do an MRI.
For patients who have been denied MRI scans for safety reasons, doctors usually recommend the CT scan with contrast as an alternative.
Labeling and recommendations
Most IVC filters that have been tested have been labeled as “MR safe”; the remainder of IVC filters that have been tested are “MR conditional.” Patients who have been treated with nonferromagnetic IVC filters can undergo MR examination any time after filter implantation. In patients who have been treated with a weakly ferromagnetic IVC filter (Gianturco bird nest IVC filter [Cook], stainless steel Greenfield vena cava filter [Boston Scientific]), it is advised that the patient wait at least six weeks before undergoing an MR examination (because these older devices initially may not be anchored as firmly in place as other devices discussed in the present context), unless there is a strong clinical indication to perform the MR examination sooner after implantation, and as long as there is no reason to suspect that the device is not positioned properly or that it is not firmly in place. Most studies of IVC filters have generally been conducted at 1.5 Tesla or less, although many IVC filters have now been evaluated at 3 tesla and deemed acceptable for MR examination.
The concept of a removable IVC filter was first thought up in 1967  However, it was not until 2003 and 2004 that the United States Food and Drug Administration drafted regulations and requirements on creating devices that were fit for retrieval from the vena cava  And still, even while the FDA did approve of the models and designs, it wasn't until 2005 that the Society of Interventional Radiology (SIR) convened a multidisciplinary conference to address the clinical application of nonpermanent vena cava filters.
Retrievable filters are fitted with a device (varying from model to model) that allows them to be easily snared and pulled back into a catheter and removed from the body, often through the jugular vein. Prior to 2004, filters that had been in the IVC for less than three weeks were considered suitable to attempt retrieval, as filters that have been in place longer might have been overgrown by cells from the IVC wall and there was an increased risk of IVC injury if the filter is dislodged. Newer designs, and developments in techniques mean that some filters can now be left in for prolonged periods and retrievals after a year are now being reported. This would include the ALN, Bard G2 and G2x, Option, Tulip and Celect filters.
It is important to note that the clinical exam prior to the removal of the filter is vital in understanding both the risk and pathophysiological effects removing the filter will have on the patient. Doctors and medical professionals must consider several key factors (see Indications for Removing IVC Filters).
The first IVC filter was created by Kazi Mobin-Uddin, MD. The Mobin-Uddin filter was later replaced by the Greenfield filter developed by Lazar Greenfield which had a lower rate of filter related complications.
- Gunther Tulip IVC Filter. Cook Medical. URL: http://www.cookmedical.com/di/di_front/images/dif_bu1.jpg. Accessed on: November 24, 2007.
- Young T, Tang H, Hughes R (2010). Young, Tim, ed. "Vena caval filters for the prevention of pulmonary embolism". Cochrane Database of Systematic Reviews (2): CD006212. doi:10.1002/14651858.CD006212.pub4. PMID 20166079.
- Kaufman, JA; Kinney TB; Streiff MB et al. (March 2006). "Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference". Journal of Vascular Interventional Radiology. 3 17: 449–459. doi:10.1097/01.rvi.0000203418-39769.0d.
- PREPIC Study, Group (19 July 2005). "Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study.". Circulation 112 (3): 416–22. doi:10.1161/circulationaha.104.512834. PMID 16009794.
- Kaufman, JA; Kinney, TB; Streiff, MB; Sing, RF; Proctor, MC; Becker, D; Cipolle, M; Comerota, AJ; Millward, SF; Rogers, FB; Sacks, D; Venbrux, AC (NaN). "Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference.". Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2 (2): 200–12. doi:10.1016/j.soard.2006.03.009. PMID 16925346. Check date values in:
- Guyatt et al. 2012, p. 21S: 2.13.2.
- Guyatt et al. 2012, p. 24S: 5.9.2.
- Guyatt et al. 2012, p. 21S: 2.13.3.
- Guyatt et al. 2012, p. 24S: 5.9.3.
- Guyatt et al. 2012, p. 21S: 2.13.
- Kinney, Thomas; Cameron, S; Sass, P; Zoller, M; Wigler, M (1 September 2006). "Inferior Vena Cava Filters". Seminars in Interventional Radiology 23 (3): 230–239. doi:10.1055/s-2006-948760. PMC 3036373. PMID 21326769.
- Mano, Tatsumi T; Sakai H et al. (2004). "A case of deep venous thrombosis with a double inferior vena cava effectively treated by suprarenal filter implantation.". pn Heart 45: 1063–1069. doi:10.1536/jhj.45.1063.
- Sartori, MT; Zampieri P; Andres AL; Prandoni P; Motta R; Miotto D (2006). "Double vena cava filter insertion in congenital duplicated inferior vena cava: a case report and literature review.". Haematologica. 6 91 (ECR30).
- Kaufman, JA. com/articles/guidelines-use-retrievable-vena-cava-filters "Guidelines for the use of retrievable vena cava filters". Touch Briefings. Retrieved 20 December 2010.
- Baumann, DS. "IVC filter placement in bariatric patients". Endovsc Today. Retrieved 2005.
- Greenfield, LJ; Peyton R; Crute S; Barnes R (1981). "Greenfield vena caval filter experience: late results in 156 patients.". Arch Surgical 116: 1451–1456. doi:10.1001/archsurg.1981.01380230065010.
- Food and Drug Administration. "Inferior Vena Cava (IVC) Filters: initial Communication: Risk of Adverse Events with Long Term Usage". United States Food and Drug Administration. Retrieved 2015-03-15.
- Ferris, EJ; McCowen TC; Carver DK; McFarland DR (1993). "Percutaneous inferior vena cava filters: follow-up of seven designs in 320 patients". Radiology 188: 851–856. doi:10.1148/radiology.188.3.8351361.
- Taheri, SA; Kulaylat MN; Johnson E; Hoover E (1992). "A complication of the Greenfield filter: fracture and distal migration of two struts, a case report". J Vascular Surgery 16: 96–99. doi:10.1016/0741-5214(92)90424-7.
- Appleberg, M; Crozier JA (1991). "Duodenal penetration by a Greenfield caval filter". Aust N Z J Surgical 61: 957–960. doi:10.1111/j.1445-2197.1991.tb00017.x.
- Howerton, RM; Watkins M; Feldman L (1991). "Late arterial hemorrage secondary to a Greenfield filter requiring operative intervention". Surgery 109: 265–268.
- Lahey, SJ; Meyer LP; Karchmer AW et al. (1991). "Misplaced caval filter and subsequent pericardial tamponade". Ann Thorac Surgery 51: 299–300. doi:10.1016/0003-4975(91)90805-z.
- Puram, B; Maley TJ; White NM; Rotman HH; Miller G (1990). "Acute myocardial infarction resulting from the migration of a Greenfield filter". Chest 98: 1510–1511. doi:10.1378/chest.98.6.1510.
- Bach, JR; Zaneuski R; Lee H (1990). "Cardiac arrhythmias from a malpositioned Greenfield filter in a traumatic quadriplegic". American Journal of Physical Medicine Rehabilitation 69: 251–253. doi:10.1097/00002060-199010000-00005.
- Villard, J; Detry L; Clermont A; Pinet F (1987). "Eight cases of Greenfield filters in the right heart cavities: their surgical treatment". Ann Radiologic 30: 102–104.
- Poillaud, C; Paillard F; Biron Y; Gouffault J (1988). "Proximal migration of a caval filter: apropos of a case". Annual Cardiological Angeiol (Paris) 37: 129–131.
- LaPlante, JS; Contractor FM; Kiproff PM; Khoury MB (1993). "Migration of the Simon nitinol vena cava filter to the chest". AJR 160: 385–386. doi:10.2214/ajr.160.2.8424358.
- Kupferschmid, JP; Dickson CS; Townsend RN; Diamond DL (1992). "Small-bowel obstruction from an extruded Greenfield filter strut: an unusual late complication". Journal of Vascular Surgery 16: 113–115. doi:10.1016/0741-5214(92)90427-a.
- Emerson, RH, Jr; Cross R; Head WC (1991). "Prophylactic and early therapeutic use of the Greenfield filter in hip and knee joint arthroplasty". Journal of Arthroplasty 6: 129–135. doi:10.1016/s0883-5403(11)80007-0.
- Olin, JW; Young JR; Graor RA; Ruschhaupt WF; Beven EG; Bay JW (1987). "Treatment of deep-vein thrombosis and pulmonary emboli in patients with primary and metastatic brain tumors: anticoagulants or inferior vena cava filters?". Archive of Internal Medicine 147: 2177–2179. doi:10.1001/archinte.147.12.2177.
- Watanabe AT, Teitelbaum GP, Gomes AS, Roehm JO Jr. MR imaging of the bird’s nest filter" Radiology 1990; 177: 578–579.
- Kiproff PM, Deeb ZL, Contractor FM, Khoury MB. Magnetic resonance characteristics of the LGM vena cava filter: technical note. Cardiovasc Intervent Radiol. 1991; 14: 254–255. Medline
- Kim D, Edelman RR, Margolin CJ, Porter DH, McArdle CR, Schlam BW, Gianturco LE, Siegel JB, Simon M. The Simon nitinol filter: evaluation by MR and ultrasound. Angiology. 1992; 43: 541–548.
- Grassi CJ, Matsumoto AH, Teitelbaum GP. Vena caval occlusion after Simon nitinol filter placement: identification with MR imaging in patients with malignancy. J Vasc Interv Radiol. 1992; 3: 535–539. Medline
- Bartels LW, Bakker CJ, Viergever MA. Improved lumen visualization in metallic vascular implants by reducing RF artifacts. Magn Reson Med. 2002; 47: 171–180.
- Liebman CE, Messersmith RN, Levin DN, Lu CT. MR imaging of inferior vena caval filters: safety and artifacts" AJR Am J Roentgenol 1988; 150: 1174–1176. FREE Full Text
- Bucker A, Neuerburg JM, Adam GB, Glowinski A, Schaeffter T, Rasche V, van Vaals JJ, Günther RW. Real-time MR guidance for inferior vena cava filter placement in an animal model. J Vasc Interv Radiol. 2001; 12: 753–756.
- Frahm C, Gehl HB, Lorch H, Zwaan M, Drobnitzky M, Laub GA, Weiss HD. MR-guided placement of a temporary vena cava filter: technique and feasibility. J Magn Reson Imaging. 1998; 8: 105–109.
- MRI safety. Institute for Magnetic Resonance Safety, Education, and Research Web site. Available at: http://www.MRIsafety.com. Accessed June 19, 2006.
- Shellock FG. Reference Manual for Magnetic Resonance Safety, Implants, and Devices: 2006 Edition. Los Angeles, Calif: Biomedical Research Publishing Group; 2006.
- Williams R, Schenk W. "A removable intracaval filter for prevention of pulmonary embolism: early experience with the use of the Eichelter catheter in patients." Surgery 1970; 68:999–1008.
- Kaufman J. "Retrievable vena cava filters." Tech Vasc Interv Radiol 2004; 7:96–104.
- McKenzie, S et al "An Australian experience of retrievable inferior vena cava filters in patients with increased risk of thromboembolic disease". International angiology, 29 (1) 53-57
- Mobin-Uddin K, Callard GM, Bolooki H, Rubinson R, Michie D, Jude JR. (1972). "Transvenous caval interruption with umbrella filter." (fee required). New England Journal of Medicine. 286(2): 55–8. PMID 5006878.
- Cain, PG (1995). "Comment on "Treatment of venous disease — The innovators". Journal of Vascular Surgery. 22(3): 341–2.
- Galanaud JP, Laroche JP, Righini M (2013). "The history and historical treatments of deep vein thrombosis". Journal of Thrombosis and Haemostasis. 11(3): 402–11.
- Hussain, SA (1999). "Kazi Mobin-Uddin, 1930-1999". Journal of Vascular Surgery. 32(2): 406–7.
- Athanasoulis, Christopher A, MD. "Complications of Vena Cava Filters" (PDF). Journal of Radiology. 3 188 (3): 614–615. Retrieved 10/11/2012. Check date values in:
- IVC filters - emedicine.com
- IVC filters - Medical College of Wisconsin
- IVC filter - GPnotebook.co.uk
- history of Lazar Greenfield and his filter[dead link] - Invention & Technology
- Greenfield Filter Informational Website